Founded in 2022, East Ocyon Bio operates in Health Tech industry. Initially focusing on creating therapies to address a range of medical conditions, the company has expanded its research and developme...
Funding stage:
Seed
Last funding:
10/12/2024
Total funding:
$4.20 Mn+
Revenue:
Investors
Employee count:
33
Last 90d
33
Last 90d
Web traffic:
4.56K
4.56K
Last 30d
Last 30d
East Ocyon Bio: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders11
Latest Filing Date24 Oct 2023- Funding Events3
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of East Ocyon Bio
As of 25 October 2023, East Ocyon Bio's equity is held by 11 shareholders, with the top three being Dinesh Kundu, Renu Kundu, and Mitul Agarwal.
Dinesh Kundu holds the largest stake in East Ocyon Bio at 28.9% as of 25 October 2023.
As of 25 October 2023, founders collectively hold 66.4% equity in East Ocyon Bio.
As of 25 October 2023, investors collectively hold 33.6% equity in East Ocyon Bio.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links